Clinical trial with Cuban vaccines shows high titers of neutralization against omicron

A clinical trial of viral neutralization at the Pedro Kourí Institute of Tropical Medicine (IPK) showed that the anti-COVID-19 Abdala and Soberana vaccines act effectively against the omicron variant of the SARS-CoV-2 virus, which causes the disease

Director of Research at the Finlay Vaccine Institute, Dagmar García Rivera, said today on Twitter that five months after receiving the last dose of Soberana, the 20 adult subjects who participated in the study showed high neutralization titers against omicron

A message from the Finlay Vaccine Institute on the same social network points out that these results were qualified as very good, and speak positively of the vaccination and booster scheme in Cuba

Reference: http://www.cubanews.acn.cu